Severe and prolonged jaundice in a lupus nephritis patient treated with cyclophosphamide
Author(s) -
Gabriella Moroni,
M. Maccario,
Silvia Fargion,
Claudio Ponticelli
Publication year - 1997
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/12.4.793
Subject(s) - medicine , lupus nephritis , jaundice , cyclophosphamide , systemic lupus erythematosus , glomerulonephritis , gastroenterology , dermatology , intensive care medicine , kidney , chemotherapy , disease
Key words: cyclophosphamide; hepatotoxicity; lupus of three intravenous methylprednisolone pulses, fol-nephritis; immunosuppressive therapy lowed by oral prednisone 0.5 mg/kg per day. A weeklater, while she was still nephrotic, it was decided todecrease prednisone to 0.3 mg/kg per day because ofan elevated intraocular pressure, and oral cyclophos-
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom